.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Cantor Fitzgerald
Healthtrust
Chubb
Merck
Cipla
McKinsey
US Army
Chinese Patent Office
UBS

Generated: September 20, 2017

DrugPatentWatch Database Preview

MOBAN Drug Profile

« Back to Dashboard

What is the patent landscape for Moban, and what generic Moban alternatives are available?

Moban is a drug marketed by Endo Pharms and is included in two NDAs.

The generic ingredient in MOBAN is molindone hydrochloride. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the molindone hydrochloride profile page.

Summary for Tradename: MOBAN

Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: see list60
Clinical Trials: see list1
Patent Applications: see list929
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MOBAN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Endo Pharms
MOBAN
molindone hydrochloride
CAPSULE;ORAL017111-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Endo Pharms
MOBAN
molindone hydrochloride
TABLET;ORAL017111-007Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Endo Pharms
MOBAN
molindone hydrochloride
TABLET;ORAL017111-004Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Endo Pharms
MOBAN
molindone hydrochloride
TABLET;ORAL017111-008Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Endo Pharms
MOBAN
molindone hydrochloride
CAPSULE;ORAL017111-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Endo Pharms
MOBAN
molindone hydrochloride
CAPSULE;ORAL017111-003Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Endo Pharms
MOBAN
molindone hydrochloride
TABLET;ORAL017111-006Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Endo Pharms
MOBAN
molindone hydrochloride
TABLET;ORAL017111-005Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Endo Pharms
MOBAN
molindone hydrochloride
CONCENTRATE;ORAL017938-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: MOBAN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Endo Pharms
MOBAN
molindone hydrochloride
TABLET;ORAL017111-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Endo Pharms
MOBAN
molindone hydrochloride
TABLET;ORAL017111-008Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Endo Pharms
MOBAN
molindone hydrochloride
TABLET;ORAL017111-007Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Endo Pharms
MOBAN
molindone hydrochloride
TABLET;ORAL017111-006Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Endo Pharms
MOBAN
molindone hydrochloride
TABLET;ORAL017111-005Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Endo Pharms
MOBAN
molindone hydrochloride
CONCENTRATE;ORAL017938-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Endo Pharms
MOBAN
molindone hydrochloride
CONCENTRATE;ORAL017938-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
AstraZeneca
McKesson
McKinsey
Novartis
Harvard Business School
Argus Health
Cerilliant
UBS
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot